I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Hereditary spastic paraplegia (HSP) is a group of neurodegenerative disorders, mainly characterized by progressive spasticity of the lower limbs. These disorders are both clinically and genetically very heterogeneous, thereby complicating their diagnoses.\[[@ref1]\] Length-dependent, retrograde axonal degeneration of the corticospinal fibers is the main pathophysiology in most of these disorders. HSP is rare, with prevalence estimates ranging from 1.2 to 9.6 per 100,000.\[[@ref2]\] HSP is classified as pure (uncomplicated) and complicated. In pure HSP, spastic paraparesis is the main clinical finding, occasionally accompanied by mild sensory deficits in the lower limbs and bladder dysfunction; whereas in complicated HSP, spastic paraparesis is accompanied by variable combinations of other manifestations, such as extra-pyramidal disturbances, ataxia, epilepsy, cognitive deficits, peripheral neuropathy, and neuroimaging abnormalities.\[[@ref1][@ref2]\]

Although the age of symptom onset varies widely from infancy to late adulthood, mostly adult case series dominate the literature. There have been only a few studies in children and none from our country.\[[@ref3][@ref4][@ref5][@ref6][@ref7]\] This often results in delay in diagnosis, failed opportunity for prenatal diagnosis, and stress in the parents. The purpose of this study is to describe our experience with pediatric HSP in a tertiary care center in southern India. We report here the clinical and genetic findings in our patients and aim to offer insights into the diagnostic difficulties of childhood-onset disease.

M[ATERIALS AND METHODS]{.smallcaps} {#sec1-2}
===================================

A retrospective review of studies on children with a diagnosis of HSP was done from January 2012 to June 2018. The diagnosis was confirmed by genetic analysis. The presenting features which included details of perinatal events, developmental milestones, and family history, as well as the neurological examination details in all patients were extracted and entered in predesigned proforma. Children were called for follow-up and their current status was noted. Siblings and parents were also examined. The details of the workup done (including metabolic and electrophysiology investigations), neuroimaging details, and the delay in the diagnosis of the disease from the onset of symptoms were also noted. Informed written consent was obtained from the patients\' parents.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

In total, 17 children were clinically suspected of HSP; out of them 11 children who had genetically confirmed HSP (details given in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}) were included in this study. The remaining had other causes such as cranio-vertebral junction anomalies, human immunodeficiency virus infection, arginase deficiency, and mild spastic paraplegia secondary to premature delivery. The age of onset of the disease was difficult to ascertain in many cases. The mean of first symptoms (as appreciated by parents) was reported at 21.7 months (range: 9--36 months), and the diagnosis of HSP was reached at 85 months (7.1 years; range: 48--156 months). The median delay in diagnosis was 72 months (6 years) after initial diagnosis. Five of them were males. Six children presented with abnormal gait and difficulty walking, four with global developmental delay, and one with delayed walking and leg pain. One child showed gait difficulties immediately after walking skills were acquired, whereas the remaining five children developed abnormal gait later in childhood. Acquisition of motor milestones was delayed in five children while cognitive development was abnormal in four cases. Sensory deficit in lower limbs was not seen in any children, while one child had bladder dysfunction. Other symptoms included attention deficit hyperactivity disorder (two), speech problems (two), epilepsy (one), optic atrophy (two), deafness (one), congenital cataract (one), sialorrhea (three), and cerebellar signs (one) \[[Table 1](#T1){ref-type="table"}\]. Perinatal history was uneventful in all children. Parental consanguinity was seen in eight children. Family history was significant in two consanguineously married couple with two affected children (patient 1 and 2) in one family, while another patient (patient 9) had family history of sibling death by 9 years with the same symptomatology.

###### 

Clinico-radiological features of hereditary spastic paraplegia

  Patient   Gender   Age at onset (in months)   Presenting symptoms          Age at diagnosis (in months)   Clinical findings                     MRI findings                                                                                
  --------- -------- -------------------------- ---------------------------- ------------------------------ ------------------------------------- ------------------------------------- ----------------------------------------------------- -------------------------------
  1         F        18                         Gait abnormality             108                            Spasticity, hyperreflexia             Spasticity, hyperreflexia             ADHD, speech delay                                    Thin CC, paucity of WM
  2         M        24                         Gait abnormality             144                            Spasticity, Achilles contracture      Spasticity, hyperreflexia             ADHD, dysarthria, optic atrophy                       Thin CC, paucity of WM
  3         M        30                         Gait abnormality             72                             Spasticity, dystonia, hyperreflexia   Spasticity, dystonia, hyperreflexia   Sialorrhea                                            WM hyperintensities
  4         F        36                         Gait abnormality             132                            Spasticity, hyperreflexia             Hyperreflexia                         None                                                  WM hyperintensities
  5         F        18                         Delayed walking, leg pain    48                             Spasticity, hyperreflexia             Dystonia, hyperreflexia               Bladder incontinence                                  Normal
  6         F        10                         Global developmental delay   60                             Spasticity, hyperreflexia             Hyperreflexia                         Optic atrophy                                         Paucity of WM, thin CC
  7         F        10                         Global developmental delay   72                             Spasticity, hyperreflexia             Hyperreflexia                         Congenital cataract, deafness                         Thin CC
  8         M        36                         Gait abnormality             156                            Spasticity, Achilles contracture      Spasticity, hyperreflexia             ID                                                    Normal
  9         M        36                         Gait abnormality             48                             Spasticity, hyperreflexia             Hyperreflexia                         None                                                  WM hyperintensities
  10        F        12                         Global developmental delay   48                             Spasticity, hyperreflexia             Spasticity, hyperreflexia             Microcephaly, epilepsy, sialorrhea                    Cerebellar atrophy
  11        M        9                          Global developmental delay   48                             Rigidity                              Spasticity, hyperreflexia             Sialorrhea, nystagmus, pontocerebellar hypoplasia-9   ACC, hypoplasia of cerebellum

MRI: Magnetic resonance imaging; ADHD: Attention deficit hyperactivity disorder; ID: Intellectual disability; CC: Corpus callosum; WM: White matter; ACC: Agenesis of corpus callosum

###### 

Spastic paraplegia types and genetic findings

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient   Consanguinity   Family history   Inheritance   Type    Gene       Zygosity                Variant (Mutation)
  --------- --------------- ---------------- ------------- ------- ---------- ----------------------- ----------------------------------------------------------------------------------
  1         Yes             Yes              AR            SPG54   DDHD2      Homozygous              Chr8:g. 38103818G\>T; c. 1125+1G\>T

  2         Yes             Yes              AR            SPG54   DDHD2      Homozygous              Chr8:g. 38103818G\>T; c. 1125+1G\>T

  3         Yes             No               AR            SPG48   AP5Z1      Homozygous              Chr7:4823011A\>G; c. 431A\>G (p.Gln144Arg)

  4         Yes             No               AR            SPG35   FA2H       Homozygous              Chr16:74753008C\>T; c. 664G\>A (p.Gly222Arg)

  5         Yes             No               AR            SPG56   CYP2U1     Homozygous              Chr4:g. 108866415ATCTG\>A; hrc. 782_785delTCTG

  6         Yes             No               AR            SPG50   AP4M1      Homozygous              Chr7:99701748G\>A; c. 577G\>A (p.Glu193Lys)

  7         No              No               AR            SPG69   RAB3GAP2   Homozygous              Chr1:220357438_220357439delAT; c. 1937_1938delAT (p.Tyr646Terfs)

  8         No              No               AR            SPG59   USP8       Compound heterozygous   Chr15:50784955 C\>C/A; c. 2292C\>C/A (p.Asn764Lys)\
                                                                                                      Chr15:50785016 A\>A/G; c. 2353A\>A/G (p.Thr785Ala)

  9         Yes             Yes              AR            SPG35   FA2H       Homozygous              Chr16:74808384-?\_74808653+?del, c.(?\_-1)\_(270+1_271-1) del, (Exon 1 deletion)

  10        No              No               AD            SPG4    SPAST      Heterozygous            Chr2:32323919 A\>A/G; c. 641A\>A/G

  11        Yes             No               AR            SPG63   AMPD2      Homozygous              Chr1:110169406G\>A; c. 752G\>A (p.Arg251Gln)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AR: Autosomal recessive; AD: Autosomal dominant; SPG: Spastic paraplegia gene

Neuroimaging details of all children are available in [Table 1](#T1){ref-type="table"}. Magnetic resonance imaging (MRI) of brain in six patients showed white-matter changes \[[Figure 1a](#F1){ref-type="fig"}\], four patients had thin corpus callosum \[[Figure 1b](#F1){ref-type="fig"}\], one patient had agenesis of corpus callosum with cerebellar hypoplasia, while one patient showed isolated cerebellar atrophy. MRI brain was normal in two children. Spinal MRI was done in all patients to exclude structural abnormalities/neurometabolic disorders. It was normal in all children. Nerve conductions tests were not done as none of them had sensory complaints and our diagnosis was made based on genetic studies.

![(a) Axial FLAIR sequence of brain of patient 8 at the age of 4 years shows predominant posteriorly white-matter patchy hyperintensities (*black arrow*). (b) Sagittal section of brain of patient 7 at the age of 2 years shows severe thinning of corpus callosum (*white arrow*)](AIAN-22-341-g001){#F1}

Genetic details are mentioned in [Table 2](#T2){ref-type="table"}. The inheritance pattern in all children was transmitted in autosomal recessive (AR) manner, except one who had heterozygous autosomal dominant (AD) mutation in *SPAST* gene (HSP type-4). Her parents, uncles, and aunts were examined clinically and found to be normal, while genetic testing was not done due to cost constraints. Nine patients with recessive inheritance showed homozygosity, while one had compound heterozygous mutation in *USP8* gene, classified as likely pathogenic and his asymptomatic parents are heterozygous carrier of this pathogenic variation. Two unrelated patients (patient 4 and 9) had mutation in *FA2H* gene causing HSP type-35, while two siblings showed same mutation in *DDHD2* gene causing HSP type-54. All patients had pathogenic or likely pathogenic mutations, except in patient 3 and 4. They had homozygous mutations in *AP5Z1* and *FA2H* gene, respectively, and classified as variant of uncertain significance. To confirm the significance of these mutations, parental sequencing was done and same variation was detected in heterozygous condition in the unaffected parents of the index patients, indicating pathogenicity.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Diagnosis of HSP in pediatric cases can be difficult in the absence of a positive family history. Although the majority of childhood-onset HSP were sporadic cases, rendering HSP as a diagnosis of exclusion, once structural lesions, neurodegenerative, and neuro-metabolic disorders have been ruled out.\[[@ref4][@ref6]\] Cerebral palsy is the most common cause of spasticity in children. Many patients are misdiagnosed with cerebral palsy, even when there is no antecedent history of perinatal event and no lesions detected on brain imaging.\[[@ref8]\] The nonprogress or very slow progression of the disease also justifies the diagnosis of cerebral palsy in many children. This deprives the parents an opportunity for prenatal diagnosis, and hence the urgency in reaching the correct diagnosis. Leukodystrophies, structural brain or spinal lesions, and rare neurometabolic disorders, including Segawa disease, arginase deficiency, and copper deficiency are other differential diagnosis of HSP.\[[@ref1][@ref6][@ref9]\] Diurnal fluctuations, neuroimaging, and metabolic screening can differentiate these disorders from HSP.

In our series, all children showed astatic or very slowly progressive course. These observations are in accordance with other pediatric series of HSP.\[[@ref4][@ref7]\] Battini *et al*. reported normal gross motor milestones in all patients in his series. In contrast, our series showed global developmental delay in one-third of children.\[[@ref4]\] Our data suggest that pediatric HSP often manifest very early even during infancy, and may present with delay in development as first manifestation.

HSP can be transmitted in an AD, AR, or X-linked (XL) manner.\[[@ref1][@ref2]\] It is mainly seen in adults compared to children and AD variety of HSP is most common, constituting around 75% of all cases.\[[@ref7]\] Majority of our patients have recessive mode of inheritance, while AD pattern of inheritance was seen in only one patient. Consanguineous union is the most likely cause for this observation, which was seen in 63.6% patients.

As described earlier, HSP is classified into two groups: pure and complicated forms. Pure form is mainly seen in adults as adult-onset AD HSP.\[[@ref7][@ref10]\] In contrast, complicated form of HSP was seen in two-thirds of patients in this series, which correlates with other studies in children.\[[@ref4][@ref5][@ref7]\] Koul *et al*.mentioned that over a period of time, most of children with HSP invariably fall into the complicated group and reported complicated HSP in 81.1% of the children in their study.\[[@ref7]\] These observations conferred that complicated form of HSP is mainly seen in children and generally inherited as AR traits, while pure form dominates in adults as AD HSP.\[[@ref4][@ref5][@ref7][@ref10]\]

MRI findings of HSP are nonspecific, including thinning of corpus callosum, nonspecific white-matter lesion, abnormal T2 hyperintensity in the posterior limb of the internal capsules, and atrophy of the brain/spinal cord.\[[@ref11]\] However, normal neuroimaging findings are also seen in some patients like in our patient 5 and 8.\[[@ref11]\] Brain and spinal MRI are usually used to rule out other differential diagnosis of HSP.

To conclude, this study confirms the genetic and clinical heterogeneity of childhood-onset HSP. The absence of positive family history should not deter a clinician from considering HSP when more obvious etiologies have been excluded. Genetic studies using next generation sequencing techniques are very helpful in reaching the diagnosis. Pediatric HSP patients can present with delayed walking or variable gait difficulties even in toddlerhood. Investigating asymptomatic first-degree relatives would be sensible in both suspected and definitively diagnosed cases of HSP.
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